ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

VTGN VistaGen Therapeutics Inc

4.50
0.00 (0.00%)
プレマーケット
最終更新日: 17:16:18
15分遅延
名称 銘柄コード 市場 種別
VistaGen Therapeutics Inc VTGN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.00 0.00% 4.50 17:16:18
始値 安値 高値 終値 前日終値
4.50
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2521:30BWVistagen Announces Positive Results from Phase 2A Pilot..
2024/4/0921:30BWVistagen to Present at the 2024 Anxiety and Depression..
2024/4/0121:30BWVistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol..
2024/3/1121:30BWVistagen to Present at Stifel 2024 Virtual CNS Days
2024/3/0708:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0708:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0708:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0708:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0114:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/2/2822:30BWVistagen to Present at TD Cowen 44th Annual Health Care..
2024/2/1508:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1506:51EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/2/1422:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1406:52EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/2/1406:33EDGAR2Form 8-K - Current report
2024/2/1406:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/1406:20BWVistagen Reports Fiscal 2024 Third Quarter Financial Results..
2024/2/0622:30BWVistagen to Report Fiscal Year 2024 Third Quarter Financial..
2024/1/0407:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0407:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0407:09EDGAR2Form 8-K - Current report
2023/12/2722:30BWVistagen Receives Notice from European Patent Office of..
2023/11/1006:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/1006:42EDGAR2Form 8-K - Current report
2023/11/1006:30BWVistagen Provides Corporate Update and Reports Fiscal 2024..
2023/11/0822:30BWVistagen to Present at Stifel 2023 Healthcare Conference
2023/11/0722:30BWVistagen to Present Positive Fasedienol Phase 3 Data and..
2023/11/0711:46EDGAR2Form 8-K/A - Current report: [Amend]
2023/11/0706:27EDGAR2Form 8-K - Current report
2023/11/0622:00BWVistagen To Report Second Quarter Financial Results and Host..
2023/11/0409:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/10/2705:13EDGAR2Form 8-K - Current report
2023/10/1705:37EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/10/1705:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/10/0705:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0705:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2023/10/0605:47EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2023/10/0521:30BWVistagen to Present at Jefferies Inaugural Biotech CNS/Neuro..
2023/10/0505:07EDGAR2Form 8-K - Current report
2023/10/0405:40EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/10/0220:30BWVistagen Announces Pricing of $100 Million Underwritten..
2023/10/0220:15EDGAR2Form 8-K - Current report
2023/9/3005:26EDGAR2Form 8-K - Current report
2023/9/1221:30BWVistagen Announces Positive Results from Exploratory Phase..
2023/9/0906:27EDGAR2Form 8-K - Current report
2023/9/0522:00BWVistagen and Fuji Enter Exclusive Negotiation Agreement for..
2023/8/2402:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2402:08EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/2221:40EDGAR2Form 8-K - Current report
2023/8/2221:30BWVistagen Appoints Cindy Anderson as Chief Financial Officer

最近閲覧した銘柄

Delayed Upgrade Clock